These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1033 related items for PubMed ID: 8508365
1. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Frazier HA, Robertson JE, Dodge RK, Paulson DF. Cancer; 1993 Jun 15; 71(12):3993-4001. PubMed ID: 8508365 [Abstract] [Full Text] [Related]
2. Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors. Honma I, Masumori N, Sato E, Takayanagi A, Takahashi A, Itoh N, Tamagawa M, Sato MA, Tsukamoto T. Urology; 2004 Oct 15; 64(4):744-8. PubMed ID: 15491713 [Abstract] [Full Text] [Related]
3. Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Thrasher JB, Frazier HA, Robertson JE, Dodge RK, Paulson DF. Cancer; 1994 Mar 15; 73(6):1708-15. PubMed ID: 8156499 [Abstract] [Full Text] [Related]
4. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion]. Słojewski M. Ann Acad Med Stetin; 2000 Mar 15; 46():217-29. PubMed ID: 11712306 [Abstract] [Full Text] [Related]
5. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP. J Urol; 2006 Dec 15; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118 [Abstract] [Full Text] [Related]
6. A fourteen-year review of radical cystectomy for transitional cell carcinoma demonstrating the usefulness of the concept of lymph node density. Cheng CW, Ng CF, Chan CK, Wong WS, Hui PE, Wong YF. Int Braz J Urol; 2006 Dec 15; 32(5):536-49. PubMed ID: 17081322 [Abstract] [Full Text] [Related]
7. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. Stein JP, Cai J, Groshen S, Skinner DG. J Urol; 2003 Jul 15; 170(1):35-41. PubMed ID: 12796639 [Abstract] [Full Text] [Related]
8. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. Esrig D, Freeman JA, Elmajian DA, Stein JP, Chen SC, Groshen S, Simoneau A, Skinner EC, Lieskovsky G, Boyd SD, Cote RJ, Skinner DG. J Urol; 1996 Sep 15; 156(3):1071-6. PubMed ID: 8709310 [Abstract] [Full Text] [Related]
9. Relevance of prostate cancer in patients with synchronous invasive bladder urothelial carcinoma: a monocentric retrospective analysis. Dell'Atti L. Arch Ital Urol Androl; 2015 Mar 31; 87(1):76-9. PubMed ID: 25847902 [Abstract] [Full Text] [Related]
10. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens]. Liedberg F, Chebil G, Davidsson T, Malmström PU, Sherif A, Månsson W. Aktuelle Urol; 2003 Sep 31; 34(5):333-6. PubMed ID: 14566661 [Abstract] [Full Text] [Related]
11. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance. Shen SS, Lerner SP, Muezzinoglu B, Truong LD, Amiel G, Wheeler TM. Hum Pathol; 2006 Jun 31; 37(6):726-34. PubMed ID: 16733214 [Abstract] [Full Text] [Related]
12. Transitional cell carcinoma of the prostate in patients undergoing radical cystoprostatectomy. Reese JH, Freiha FS, Gelb AB, Lum BL, Torti FM. J Urol; 1992 Jan 31; 147(1):92-5. PubMed ID: 1729557 [Abstract] [Full Text] [Related]
13. [Prognostic factors of survival in infiltrating urothelial bladder carcinoma. A retrospective study of 158 patients treated by radical cystectomy]. Thieblemont C, Fendler JP, Trillet-Lenoir V, Petris C, Chauvin F, Brunat-Mentigny M, Devaux Y, Devonec M, Gérard JP, Perrin P. Bull Cancer; 1996 Feb 31; 83(2):139-46. PubMed ID: 8652908 [Abstract] [Full Text] [Related]
14. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes. Ma B, Li H, Zhang C, Yang K, Qiao B, Zhang Z, Xu Y. Eur J Surg Oncol; 2013 Oct 31; 39(10):1150-6. PubMed ID: 23721764 [Abstract] [Full Text] [Related]
15. External validation of extranodal extension and lymph node density as predictors of survival in node-positive bladder cancer after radical cystectomy. Masson-Lecomte A, Vordos D, Hoznek A, Yiou R, Allory Y, Abbou CC, de la Taille A, Salomon L. Ann Surg Oncol; 2013 Apr 31; 20(4):1389-94. PubMed ID: 23208127 [Abstract] [Full Text] [Related]
17. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour. Solsona E, Iborra I, Rubio J, Casanova J, Almenar S. BJU Int; 2004 Dec 31; 94(9):1258-62. PubMed ID: 15610101 [Abstract] [Full Text] [Related]
19. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis. Mitra AP, Bartsch CC, Bartsch G, Miranda G, Skinner EC, Daneshmand S. Urol Oncol; 2014 Feb 31; 32(2):117-27. PubMed ID: 23477878 [Abstract] [Full Text] [Related]
20. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients. Stein JP, Clark P, Miranda G, Cai J, Groshen S, Skinner DG. J Urol; 2005 Apr 31; 173(4):1163-8. PubMed ID: 15758728 [Abstract] [Full Text] [Related] Page: [Next] [New Search]